Moritz Seiffert

Crossing the aortic valve can pose significant challenges, particularly in cases involving a horizontal aorta, bulky asymmetric calcifications, or prior prosthesis implantation in valve-in-valve procedures. While some TAVI devices feature deflectable delivery systems to enhance coaxiality, current self-expanding valves lack this capability. When standard techniques like...

Discover the risks and benefits of TAVI in patients with low surgical risk, building on the data of the latest randomised trial in this field, the DEDICATE trial, of which Moritz Seiffert was one of the leading investigators.

According to Medical Director of PCR Webinars, Dejan Milasinovic, two novel additions to the platform will increase the interactive experience and take webinar­ based learning to a new level.

Luigi Biasco interviews Moritz Seiffert about the one-year outcomes of the randomized DEDICATE-DZHK6 trial which he presented at ACC.24 in Atlanta.

TAVR was found non-inferior to SAVR in low-risk patients, showing decreased rates of death or stroke at one year. The trial supports TAVR's safety and efficacy, highlighting...

Consult this session if you want to understand how to optimize the hemodynamic performance after VinV procedures, to identify patients at risk for coronary occlusion and how to prevent this in VinV procedures, and to learn how to gain safe vascular access in challenging peripheral anatomies.

Watch this session to appreciate why it is better to tackle difficult transfemoral access rather than considering alternative access strategies and understand how intravascular lithotripsy mitigates procedural risk.

To learn more about the prevention and treatment of complications related to valve interventions, watch these cases, including the case of a 70 year old with Iatrogenic aortic stenosis, the closure of paravalvular leaks of a 68 year old male affected by chronic aortic dissection or...